# The Effect of Rituximab on the Development of Anti-Donor Antibodies

> **NCT00695097** · NA · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 18 (actual)

## Conditions studied

- Renal Transplant Rejection

## Interventions

- **DRUG:** Rituximab
- **DRUG:** No Rituximab

## Key facts

- **NCT ID:** NCT00695097
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2014-03-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00695097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00695097, "The Effect of Rituximab on the Development of Anti-Donor Antibodies". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00695097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*